Literature DB >> 27035578

Vascular Changes and Neurodegeneration in the Early Stages of Diabetic Retinopathy: Which Comes First?

Karoline Boegeberg Jonsson1, Ulrik Frydkjaer-Olsen, Jakob Grauslund.   

Abstract

INTRODUCTION: Neurodegeneration is an early component of diabetic retinopathy (DR). It is unclear whether neurodegeneration is an independent factor or a consequence of damaged retinal vasculature. The aims of this study were to review the literature concerning neurodegeneration in diabetic patients without or with early DR, and to examine whether neurodegeneration precedes visible vasculopathy in the pathogenesis of DR.
METHODS: A systematic literature search was performed to identify studies which used optical coherence tomography (OCT) or multifocal electroretinography (mfERG) to detect neurodegeneration in patients with no or mild DR as compared to healthy controls. Outcome measures were mean retinal thickness (RT), mean retinal nerve fiber layer (RNFL) thickness and ganglion cell layer (GCL) thickness. Also, mfERG amplitude and implicit time were analyzed.
RESULTS: Eleven studies which used mfERG and/or OCT to detect neurodegeneration were included. Two OCT studies found significant thinning of RT, 2 found thinning of RNFL, whereas 1 found thickening of RT, RNFL and GCL in patients without DR. Two mfERG studies found a significant delay of implicit time in the same patient group. Retinal thinning and delay of implicit time were also detected in patients with mild DR.
CONCLUSION: Retinal neurodegeneration is an early component of DR, which can precede visible vasculopathy.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2016        PMID: 27035578     DOI: 10.1159/000444498

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  31 in total

Review 1.  Spermine oxidase: A promising therapeutic target for neurodegeneration in diabetic retinopathy.

Authors:  S Priya Narayanan; Esraa Shosha; Chithra D Palani
Journal:  Pharmacol Res       Date:  2019-06-15       Impact factor: 7.658

Review 2.  A Perspective on the Müller Cell-Neuron Metabolic Partnership in the Inner Retina.

Authors:  A K Toft-Kehler; D M Skytt; Miriam Kolko
Journal:  Mol Neurobiol       Date:  2017-09-19       Impact factor: 5.590

3.  Progression of Primary Open-Angle Glaucoma in Diabetic and Nondiabetic Patients.

Authors:  Huiyuan Hou; Takuhei Shoji; Linda M Zangwill; Sasan Moghimi; Luke J Saunders; Kyle Hasenstab; Elham Ghahari; Patricia Isabel C Manalastas; Tadamichi Akagi; Mark Christopher; Rafaella C Penteado; Robert N Weinreb
Journal:  Am J Ophthalmol       Date:  2018-02-13       Impact factor: 5.258

4.  Central Macular Thickness in Diabetic Patients: A Sex-based Analysis.

Authors:  Edmund Arthur; Stuart B Young; Ann E Elsner; Karthikeyan Baskaran; Joel A Papay; Matthew S Muller; Thomas J Gast; Bryan P Haggerty; Christopher A Clark; Victor E Malinovsky; Shane G Brahm; Taras V Litvin; Glen Y Ozawa; Jorge A Cuadros
Journal:  Optom Vis Sci       Date:  2019-04       Impact factor: 1.973

Review 5.  Obstructive Sleep Apnoea, Other Sleep Parameters and Diabetic Retinopathy.

Authors:  Dayna Yong Wei Wei; Merwyn Chew; Charumathi Sabanayagam
Journal:  Curr Diab Rep       Date:  2021-12-13       Impact factor: 4.810

6.  Structural and functional changes among diabetics with no diabetic retinopathy and mild non-proliferative diabetic retinopathy using swept-source optical coherence tomography angiography and photopic negative response.

Authors:  Karthika Pandurangan; Ramya Sachidanandam; Parveen Sen
Journal:  Doc Ophthalmol       Date:  2022-07-28       Impact factor: 1.854

7.  Early retinal functional alteration in relation to diabetes duration in patients with type 2 diabetes without diabetic retinopathy.

Authors:  Sangeetha Srinivasan; Sobha Sivaprasad; Ramachandran Rajalakshmi; Ranjit Mohan Anjana; Rayaz A Malik; Vaitheeswaran Kulothungan; Viswanathan Natarajan; Rajiv Raman; Muna Bhende
Journal:  Sci Rep       Date:  2022-07-06       Impact factor: 4.996

8.  Is primary open-angle glaucoma a risk factor for diabetic retinopathy?

Authors:  Temiloluwa M Abikoye; Tunji S Oluleye; Olufisayo T Aribaba; Kareem O Musa; Oluwatobi O Idowu; Adeola O Onakoya
Journal:  Int Ophthalmol       Date:  2020-07-21       Impact factor: 2.031

9.  Alterations of retinal thickness measured by optical coherence tomography correlate with neurophysiological measures in diabetic polyneuropathy.

Authors:  Yuichiro Yamada; Tatsuhito Himeno; Kotaro Tsuboi; Yuka Shibata; Miyuka Kawai; Yuriko Asada-Yamada; Yusuke Hayashi; Emi Asano-Hayami; Tomohide Hayami; Yuichiro Ishida; Yohei Ejima; Mikio Motegi; Saeko Asano; Makoto Kato; Eriko Nagao; Hiromi Nakai-Shimoda; Takahiro Ishikawa; Yoshiaki Morishita; Masaki Kondo; Shin Tsunekawa; Yoshiro Kato; Takayuki Nakayama; Motohiro Kamei; Jiro Nakamura; Hideki Kamiya
Journal:  J Diabetes Investig       Date:  2020-12-30       Impact factor: 4.232

10.  Long-term structural retinal changes in patients with optic neuritis related to multiple sclerosis.

Authors:  Maria Rene Andersen; Malte Roar; Tobias Sejbaek; Zsolt Illes; Jakob Grauslund
Journal:  Clin Ophthalmol       Date:  2017-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.